Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Pharmacotherapy. 2020 Oct;40(10):1042–1053. doi: 10.1002/phar.2461

Table 5.

Polypharmacy and Hyperpolypharmacy by Baseline Characteristics of the Aspirin in Reducing Events in the Elderly Study Cohort at Enrollment

0–4 Medications, n=14,026 5–9 Medications, n=4665 10 or More Medications, n=423 Adjusted Odds Ratioa(95% CI)
Age 73.8 (71.6–77.4) 74.6 (71.8–78.5) 74.5 (71.8–78.2) 1.03 (1.02–1.03)
 65–74 60 (8442) 53 (2488) 55% (234) Reference
 75–84 36 (5072) 42 (1970) 42% (176) 1.29 (1.21–1.38)
 85 or older 4 (512) 4 (207) 3% (13) 1.29 (1.09–1.52)
Race
 White 92 (12,891) 90 (4192) 87 (367) Reference
 Non-White 8 (1135) 10 (473) 13 (56) 1.24 (1.08–1.43)
Years of education
 ≥ 12 years 57 (7953) 49 (2298) 53 (226) Reference
 < 12 years 43 (6072) 51 (2367) 47 (197) 1.39 (1.3–1.49)
GI complaintb 16 (2213) 32 (1516) 45 (192) 2.63 (2.4–2.9)
Hypertension 69 (9662) 89 (4130) 95 (403) 3.88 (3.53–4.27)
Diabetes mellitus 7 (980) 20 (938) 30 (127) 3.84 (3.49–4.21)
CKD 22 (3086) 32 (1483) 40 (171) 1.73 (1.61–1.86)
Not frail 63 (8854) 48 (2255) 32 (137) Reference
Prefrail 36 (4983) 47 (2213) 59 (251) 1.83 (1.72–1.96)
Frail 1 (189) 4 (197) 8 (35) 4.54 (3.74–5.52)
MCSc 55.9 ± 6.74 55.2 ± 7.96 54.2 ± 9.2 1.01 (1.01–1.02)
PCSc 49.9 ± 7.73 44.4 ± 9.72 38.9 ± 10.27 1.08 (1.07–1.08)
3MSc 93.6 ± 4.61 93.0 ± 4.66 93.1 ± 4.48 1.03 (1.03–1.04)
Grip strengthc 26.3 (20.3–35.0) 22.7 (18.0–30.0) 21.3 (16.7–26.8) 1.03 (1.03–1.04)
Gait speed 2.91 (2.55–3.34) 3.17 (2.75–3.74) 3.44 (2.96–4.24) 1.51 (1.46–1.56)
CES-D-10 < 8 92 (12,852) 87 (4050) 78 (329) Reference
CES-D-10 8 or more 8 (1171) 13 (614) 22 (94) 1.72 (1.55–1.9)

3MS = Modified Mini-Mental Examination score; CES-D-10 = Center of Epidemiology Studies Short Depression Scale score; CI = confidence interval; CKD = chronic kidney disease; GI = gastrointestinal; MCS = Mental Component Score from the 12-Item Short Form Survey; PCS = Physical Component Score from the 12-Item Short Form Survey; PIMs = potentially inappropriate medications.

Data are presented as percentage of column (n), median (interquartile range), or mean ± SD unless otherwise indicated. CKD is defined as defined as an estimated glomerular filtration rate of less than 60 ml/minute/1.73 m2 or a urine albumin creatinine ratio of three or more. Grip strength is for dominant hand.

a

Ordinal log, 0–4 medications (reference) adjusted for country and sex.

b

Data collection about GI complaints was introduced part way through recruitment. Percentage is of the total number of participants who were asked about GI complaints, which included self-report of gastro-esophageal reflux disease, gastritis, or dyspepsia.

c

Odds ratios for MCS, PCS, grip strength, and 3MS is per one-unit decrease.